$2.07 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 81 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 85.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Buy | CELGENE CORP | $150,009,000 | +6.4% | 1,498,738 | +27.3% | 7.25% | +20.7% |
| BMRN | Buy | BIOMARIN PHARMAC INC | $122,824,000 | -13.8% | 1,489,137 | +9.5% | 5.94% | -2.2% |
| AMGN | Buy | AMGEN INC | $102,372,000 | +25.0% | 682,797 | +35.3% | 4.95% | +41.8% |
| INCY | Buy | INCYTE CORPORATION | $83,597,000 | -31.6% | 1,153,540 | +2.3% | 4.04% | -22.5% |
| FOLD | Buy | AMICUS THERAPEUTICS | $77,961,000 | +0.8% | 9,226,145 | +15.7% | 3.77% | +14.3% |
| VRTX | Buy | VERTEX PHARMACEUTICL | $71,261,000 | -17.7% | 896,479 | +30.3% | 3.45% | -6.7% |
| SHPG | Buy | SHIRE PLCsp adr | $69,679,000 | +106.4% | 405,347 | +146.2% | 3.37% | +134.1% |
| NBIX | Buy | NEUROCRINE BIOSCIENC | $65,256,000 | +176.8% | 1,649,963 | +296.0% | 3.16% | +213.9% |
| DXCM | Buy | DEXCOM INC | $38,815,000 | +30.7% | 571,559 | +57.6% | 1.88% | +48.1% |
| XLRN | Buy | ACCELERON PHARMA | $37,929,000 | -30.6% | 1,437,235 | +28.2% | 1.83% | -21.3% |
| PTLA | New | PORTOLA PHARMACEUTIC | $32,498,000 | – | 1,593,039 | +100.0% | 1.57% | – |
| ALDR | Buy | ALDER BIOPHARMACEU | $31,620,000 | +2.4% | 1,291,153 | +38.1% | 1.53% | +16.1% |
| ICPT | Buy | INTERCEPT PHARMACE | $31,533,000 | -4.1% | 245,447 | +11.5% | 1.52% | +8.9% |
| ALGN | Buy | ALIGN TECH INC | $30,711,000 | +20.8% | 422,486 | +9.4% | 1.48% | +37.0% |
| TSRO | Buy | TESARO INC | $30,375,000 | +43.3% | 689,869 | +70.3% | 1.47% | +62.5% |
| ADPTQ | Buy | ADEPTUS HEALTH INCcl a | $24,703,000 | +141.3% | 444,783 | +136.9% | 1.19% | +173.9% |
| NXTM | Buy | NXSTAGE MEDICAL | $24,693,000 | +60.7% | 1,647,309 | +134.9% | 1.19% | +82.3% |
| ACHC | Buy | ACADIA HEALTHCARE | $23,080,000 | +132.6% | 418,805 | +163.6% | 1.12% | +163.8% |
| ADXS | Buy | ADVAXIS INC | $19,631,000 | +9.0% | 2,174,015 | +21.4% | 0.95% | +23.6% |
| ACAD | New | ACADIA PHARMACEUTCLS | $19,312,000 | – | 690,700 | +100.0% | 0.93% | – |
| SGNT | Buy | SAGENT PHARMACEUTI | $18,271,000 | +41.7% | 1,501,296 | +85.3% | 0.88% | +60.5% |
| IONS | Buy | IONIS PHARMACEUTICAL | $17,549,000 | +88.9% | 433,300 | +188.9% | 0.85% | +114.4% |
| QURE | Buy | UNIQURE N.V. | $16,956,000 | -10.0% | 1,427,313 | +25.4% | 0.82% | +2.1% |
| PTCT | Buy | PTC THERAPEUTICS I | $16,842,000 | -67.2% | 2,615,241 | +64.9% | 0.81% | -62.8% |
| PRTA | New | PROTHENA CORP PLC | $16,386,000 | – | 398,100 | +100.0% | 0.79% | – |
| OPHT | Buy | OPHTHOTECH CORP | $15,095,000 | -33.5% | 357,106 | +23.6% | 0.73% | -24.5% |
| SAGE | New | SAGE THERAPEUTICS | $13,500,000 | – | 421,084 | +100.0% | 0.65% | – |
| TMH | New | TEAM HEALTH HLDGS | $11,247,000 | – | 269,000 | +100.0% | 0.54% | – |
| TDOC | Buy | TELADOC INC | $9,365,000 | -9.7% | 975,533 | +69.0% | 0.45% | +2.5% |
| AVXS | New | AVEXIS INC | $8,107,000 | – | 297,600 | +100.0% | 0.39% | – |
| NUVA | New | NUVASIVE INC | $8,090,000 | – | 166,300 | +100.0% | 0.39% | – |
| DNAI | Buy | PRONAI THERAPEUTICS | $7,664,000 | -46.7% | 1,137,073 | +24.9% | 0.37% | -39.5% |
| RGNX | Buy | REGENXBIO INC | $7,347,000 | +26.2% | 680,241 | +94.0% | 0.36% | +43.1% |
| AMSG | New | AMSURG CORP | $7,191,000 | – | 96,400 | +100.0% | 0.35% | – |
| MNTA | Buy | MOMENTA PHARMACEUTIC | $6,288,000 | +121.0% | 680,552 | +254.9% | 0.30% | +151.2% |
| COLL | New | COLLEGIUM PHARMACEUT | $5,343,000 | – | 294,400 | +100.0% | 0.26% | – |
| MOH | New | MOLINA HEALTHCARE | $5,224,000 | – | 81,000 | +100.0% | 0.25% | – |
| ABMD | New | ABIOMED INC | $5,082,000 | – | 53,600 | +100.0% | 0.25% | – |
| ARAY | New | ACCURAY INC | $4,462,000 | – | 771,950 | +100.0% | 0.22% | – |
| PRAH | New | PRA HEALTH SCIENCE | $4,182,000 | – | 97,800 | +100.0% | 0.20% | – |
| IART | New | INTEGRA LIFESCIENCE | $4,079,000 | – | 60,560 | +100.0% | 0.20% | – |
| SCAI | New | SURGICAL CARE AFFI | $3,675,000 | – | 79,400 | +100.0% | 0.18% | – |
| WMGI | New | WRIGHT MED GROUP N V | $3,020,000 | – | 181,935 | +100.0% | 0.15% | – |
| ENTL | New | ENTELLUS MED INC | $2,722,000 | – | 149,665 | +100.0% | 0.13% | – |
| ANAC | New | ANACOR PHARMACEUTI | $2,485,000 | – | 46,500 | +100.0% | 0.12% | – |
| LCI | New | LANNETT CO INC | $2,330,000 | – | 129,957 | +100.0% | 0.11% | – |
| TNDM | New | TANDEM DIABETES CA | $2,340,000 | – | 268,690 | +100.0% | 0.11% | – |
| XENT | New | INTERSECT ENT INC | $2,195,000 | – | 115,540 | +100.0% | 0.11% | – |
| NVAX | New | NOVAVAX INC | $2,129,000 | – | 412,500 | +100.0% | 0.10% | – |
| New | PRONAI THERAPEUTICS | $1,359,000 | – | 201,660 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.